Nuclear & Uranium ETF EU 2026: NUKL vs U3O8 UCITS

TL;DR

EU investors can access nuclear/uranium through three UCITS routes: Sprott Uranium Miners UCITS (U3O8/URNM) at 0.85% TER, Global X Uranium UCITS (URNU) at 0.65% TER, and HANetf Sprott Junior Uranium Miners (URNJ) at 0.85% TER. AUM ranges from ~EUR 110M (URNJ) to ~EUR 750M (URNU). Adjacency: VanEck Uranium and Nuclear Technologies (NUKL) at 0.55% TER covers the broader nuclear ecosystem including SMR developers and utilities. 3-year annualised return is +22% to +45%, driven by data centre power demand, COP28 nuclear commitments and supply tightness. Key risks: uranium price volatility (U3O8 spot has 60%+ annual swings), regulatory cycle (NRC, ASN, IAEA approvals are multi-year), and single-mine concentration (Cameco, Kazatomprom dominate). Informational content, not investment advice. Thematic ETFs concentrate risk; consider role in overall portfolio.

---

Why Nuclear in 2026

Nuclear is the biggest narrative shift in energy investing post-2022. Key drivers:

• COP28 declaration. 25 countries (US, UK, France, Japan, Korea, Sweden, etc.) committed to tripling nuclear capacity by 2050 at COP28 (December 2023). COP29 and COP30 reaffirmed.
• Hyperscaler power deals. Microsoft signed 20-year PPA to restart Three Mile Island Unit 1 (2024); Amazon AWS bought a data centre adjacent to Susquehanna nuclear; Google partnered with Kairos Power for SMR deployment.
• Uranium supply gap. Western utilities accelerated decoupling from Russian/Kazakh enrichment (Rosatom controls ~46% of global enrichment); restart of Cameco Cigar Lake, Paladin Langer Heinrich, Kazatomprom production constraints — primary supply at ~150M lbs U3O8/year vs demand ~180M lbs.
• Spot uranium price. Moved from USD 30/lb (2020) to USD 100+/lb (Jan 2024), settled around USD 75-85/lb mid-2026.
• SMR commercialisation. NuScale (NYSE: SMR), Oklo (NYSE: OKLO), TerraPower, X-energy, Holtec — first deployments targeted 2028-2030, multi-billion order pipelines.
• EU policy. France, Sweden, Finland, Czechia, Poland, Netherlands actively building or restarting nuclear; Germany remains the outlier post-2023 shutdown.

Historical data shows uranium equities are highly cyclical — 2007 peak followed by 80% drawdown through 2016; 2020-2024 bull run delivered 200-400% gains on top miners. Many thematic investors include uranium as a commodity-cycle bet with structural demand tailwind.

---

Top UCITS Nuclear/Uranium ETFs Comparison

The iShares NUKE (0.40%) is the newest and cheapest. Sprott U3O8 is the largest pure-miner play. NUKL offers the broadest "nuclear ecosystem" exposure (miners + utilities + SMR + enrichment).

Additional adjacent: Yellow Cake plc (LSE: YCA) — not an ETF but a listed vehicle holding ~21.7M lbs physical uranium directly. Some investors hold YCA as a complement.

---

Holdings Breakdown and Overlap

Top recurring names across UCITS uranium/nuclear ETFs at end-2025:

Miners: Cameco, Kazatomprom, Paladin Energy, Boss Energy, Denison Mines, Energy Fuels, NexGen Energy, Uranium Energy Corp, Deep Yellow.

Enrichment / fuel: Centrus Energy, Urenco (private), Orano (private).

Utilities operating nuclear: Constellation Energy, Vistra, Public Service Enterprise Group, EDF (private float), Korea Electric Power.

SMR / advanced reactors: NuScale Power, Oklo, BWX Technologies, Lightbridge.

Equipment & engineering: Westinghouse (Brookfield/Cameco), Mitsubishi Heavy, Doosan Enerbility.

Overlap analysis:

• U3O8 vs URNU: ~85% overlap (both pure-miner indices)
• NUKL vs U3O8: ~45% overlap (NUKL includes utilities and SMR)
• NUKE vs NUKL: ~80% overlap

Geographic exposure (U3O8 approx end-2025):

• Canada: 35% (Cameco, NexGen, Denison)
• Kazakhstan: 22% (Kazatomprom)
• Australia: 18% (Paladin, Boss, Deep Yellow)
• United States: 12% (UEC, Energy Fuels, Centrus)
• Africa (Namibia, Niger): 8%
• Other: 5%

NUKL adds significant US utility weight (Constellation, Vistra) and Korea (KEPCO) — shifts to ~45% US / 25% Canada / 15% Australia / 15% other.

---

Performance Snapshot

Historical data (approximate annualised total return in EUR, to end-2025):

Uranium equities decisively outperformed broad indices over 2-3 years. Volatility is 2-3x MSCI World — drawdowns of 25-40% are normal mid-cycle even in a structural bull market.

Tracking error: U3O8 and URNU 0.20-0.30% annualised — slightly elevated due to mining-stock liquidity and rebalancing complexity.

---

Does Nuclear/Uranium Outperform Broad Index After Fees

Yes, clearly, over 2-3 years. Uranium ETFs delivered 27-35% annualised vs 18% for MSCI World since 2023. The post-2020 uranium bull market is multi-year and arguably mid-cycle — uranium bull cycles historically last 4-7 years (2003-2007 prior cycle; current cycle 2020-?).

But: commodity cycles end. Spot uranium peaked at USD 137/lb in January 2024, settled around USD 75-85/lb by mid-2026 — a 35%+ commodity drawdown despite continued positive structural narrative. Equity prices followed with 30-40% mid-cycle drawdowns in 2024-2025.

The investment case requires commodity cycle conviction plus tolerance for sustained drawdowns. Over 10+ years, uranium equity returns have been lumpy — the 2007-2016 bear market was brutal.

---

Total Cost for EU Investor

For a EUR 10,000 position in U3O8 held 5 years:

• TER: 0.85%/year = ~EUR 425 cumulative
• Spread (Xetra): ~0.20-0.30% (uranium ETFs have wider spreads than broad-market UCITS)
• Commission: typically EUR 0-1 at Trade Republic
• FX impact: ~35% CAD, ~22% KZT-linked, ~18% AUD, ~12% USD — most diversified FX of any thematic, but exotic currencies (KZT/AUD/CAD)

Total expected drag: ~1.05-1.20%/year — among the highest UCITS thematic.

iShares NUKE at 0.40% TER is significantly cheaper if you prefer broader nuclear ecosystem exposure (not pure miners). NUKL at 0.55% is the middle ground.

---

Tax Treatment by Country

• Germany. Equity ETF Vorabpauschale + 30% Teilfreistellung. Mining ETFs typically classified as equity quota >50% — qualifying.
• France. Uranium thematic ETFs are not PEA-eligible (non-EEA dominant). CTO + PFU 30%.
• Italy. 26% on realised gains.
• Spain. 19-28% sliding scale.
• Netherlands. Box 3.
• Poland. 19% Belka on sale; PIT-38. Poland's domestic nuclear programme (KHNP partnership in Lubiatowo-Kopalino, Westinghouse Pątnów decision) creates strong macro alignment.

SFDR: most uranium/nuclear ETFs classify as Article 6 SFDR — no sustainability claim. The 2022 EU Taxonomy update added nuclear as transitional sustainable activity (under specific conditions), which softened institutional ESG exclusion but didn't reverse it broadly.

---

Broker Availability

Polish IKE/IKZE users: U3O8, URNU, NUKL widely supported. Polish nuclear programme (Lubiatowo-Kopalino with Westinghouse AP1000, Polish SMR plans) creates strong narrative alignment for domestic investors.

---

When Nuclear/Uranium ETF Makes Sense

1. Energy transition long-horizon bet. COP28 tripling commitment + AI data centre demand + 24/7 baseload need = multi-decade nuclear renaissance thesis.
2. Commodity-cycle allocator. Investors who understand uranium spot price drives mining equity 3-5x leverage; willing to hold through 30-40% drawdowns.
3. Inflation/scarcity hedge. Hard-asset exposure with supply-side bottlenecks.
4. SMR / future-energy thesis. NUKL captures SMR developer optionality (Oklo, NuScale) alongside legacy miners — diversifies risk.
5. Polish investor with macro alignment. Polish nuclear build-out programme reinforces structural narrative.

---

When Nuclear/Uranium ETF Does NOT Make Sense

1. Risk-averse income investor. No dividend yield, 30-40% drawdowns normal.
2. ESG-mandated investor. Despite EU taxonomy update, most ESG mandates still exclude nuclear.
3. Short-term tactical play. Spot uranium can move 20%+ in a quarter on inventory disclosures or restart news.
4. Already heavy commodity exposure. Uranium correlates moderately with broader mining/commodities — diversification benefit lower than it appears.
5. Investor needing transparent fundamentals. Mining valuations depend on grade, recovery, capex, geopolitical permits — opaque to non-specialists.

---

Sector-Specific Risks

• Uranium spot volatility. U3O8 has moved 40-60% in single years (both directions). Mining equity beta to spot is ~2.5-3x. ETF drawdowns of 30%+ in stable-narrative years are normal.
• Single-mine concentration. Cameco's Cigar Lake (Saskatchewan) produces ~10% of global mined uranium; a multi-month outage moves the global supply/demand balance materially. Same for Kazatomprom production guidance changes.
• Geopolitical concentration. Kazakhstan ~40% of global production; Russia ~46% of global enrichment. Sanctions or political shifts have outsized impact.
• Regulatory cycle. US NRC, French ASN, UK ONR approvals for reactor designs take 5-10 years. SMR commercial deployment timelines slipping is a real risk.
• Demand realisation lag. Hyperscaler PPAs and COP28 commitments are forward-looking; actual reactor restarts and new builds take 8-15 years from decision to grid connection. Equity prices may decouple from fundamentals.
• Subsidy dependence. Civil Nuclear Credit Program (US) and EU Taxonomy alignment shape financing economics — political shifts can disrupt.
• Yellow Cake closure / premium swings. YCA (LSE) trades at variable premium/discount to NAV (typically -10% to +5%); ETF investors get more diversified exposure but lose the "physical uranium" purity.

---

Worked Example: EUR 10,000 DCA Over 5 Years

EUR 167/month into U3O8 for 60 months (EUR 10,020 total). Using a blended 5-year approximation including the 2020-2025 uranium bull cycle (~24% annualised):

• Final value (approximate): EUR 17,800
• Net gain: EUR 7,780 (+77.6%)

Same DCA into VWCE:

• Final value: EUR 13,180
• Net gain: EUR 3,160 (+31.5%)

Difference: ~EUR 4,620 in favour of uranium ETF. This is the cyclical outperformance — entering a multi-year commodity bull market. Forward-looking, an investor cannot assume the same return profile. If spot uranium reverts to USD 50-60/lb, mining equity could drop 40-50% before any structural re-rating. Cyclical timing matters, even in structurally bullish themes.

---

Polish Reader Angle

For Polish investors:

• Macro alignment. Poland is building its first commercial nuclear power plant in Lubiatowo-Kopalino (Westinghouse AP1000, target online 2033); KHNP separately developing Pątnów with Polish utilities; Polish SMR initiatives with Synthos/Last Energy. Nuclear narrative is structurally pro-Polish.
• IKE/IKZE viability. U3O8 (IE000NDWFGA5), URNU, NUKL supported in BOSSA IKE and mBank IKE. Inside IKE the cyclical commodity returns compound tax-free — meaningful for long-horizon investors.
• DTT relief. Ireland-domiciled ETFs get 15% WHT on US-sourced dividends (Ireland-US treaty). However, uranium miners pay modest dividends (most retain capital for capex), so the WHT saving is small (~5-10 bps annually).
• FX risk. ~35% CAD, ~22% KZT, ~18% AUD — diversified but exotic. PLN moves vs these currencies can dominate fund-level performance in any given year.
• Polish broker considerations. mBank Brokers and BOSSA support U3O8, URNU on Xetra/LSE. Commission ~0.29% min PLN 19 for foreign markets — material for small DCAs.

Tracking thematic allocation drift

Uranium is the most cyclical thematic in a portfolio — a 5% sleeve can become 12% in two good years and drop back to 4% in one bad year. Freenance tracks per-theme weight evolution, correlation to broader commodities and your core MSCI World, and the Financial Freedom Runway impact of trimming vs holding — particularly useful for cyclical themes where rebalancing is both more important and more painful.

---

FAQ

Q: Is U3O8 the same as the US-listed URNM? Yes, same Sprott Uranium Miners Index, different wrappers. URNM is US-listed (NYSE Arca), not available to EU retail under MiFID II. U3O8 (HANetf/Sprott) is the UCITS Ireland-domiciled equivalent.

Q: Should I prefer U3O8 (pure miners) or NUKL (broader nuclear)? NUKL gives broader exposure to nuclear utilities (Constellation, Vistra) and SMR developers — lower commodity beta, more diversified. U3O8 is higher beta to uranium spot price. If your thesis is the commodity, U3O8; if your thesis is the broader energy theme, NUKL.

Q: What about Yellow Cake (YCA) — should I hold physical uranium instead? YCA holds physical pounds of U3O8 — purest commodity exposure without mining operational risk. But: no production growth, no dividends, trades at variable premium/discount to NAV. Many investors hold a small YCA position alongside U3O8 for diversification.

Q: How do I value an ETF when uranium spot is so volatile? Mining equities trade on forward spot expectations and operating leverage. A USD 80/lb spot environment supports current valuations; sustained USD 100+/lb would drive 30-50% more upside; USD 50/lb would drive 30-50% downside. Sensitivity to spot is the key valuation lever.

Q: Are there ESG-screened nuclear ETFs? Mainstream Article 8 SFDR exclude nuclear. The 2022 EU Taxonomy update added nuclear as transitional sustainable — some specialised "transition" funds include uranium/nuclear, but mainstream ESG funds still exclude.

Q: Should I worry about Russia/Kazakhstan supply disruption? Both risks and opportunities. Western utility decoupling from Rosatom enrichment is bullish for Western miners and conversion/enrichment plays (Centrus, Cameco, Urenco). But Kazatomprom is 27% of global mined uranium — production cuts or political disruptions move the spot price 20%+ short-term.

---

Sources

• Issuer factsheets and KIIDs: HANetf, Sprott, Global X, VanEck, BlackRock (iShares)
• Index methodology: Sprott (North Shore Global Uranium Mining Index), MarketVector, Solactive
• Tax: country tax authority general guidance; consult local tax adviser
• Uranium spot: publicly disclosed corporate fuel-cycle reports
• COP28 nuclear declaration publicly available
• Polish nuclear programme publicly disclosed

Informational content, not investment advice. Thematic ETFs concentrate risk; consider role in overall portfolio.